{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:58:25Z","timestamp":1792540705352,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02835-w","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:05:04Z","timestamp":1748426704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Synthesis, anticancer evaluation, and electrochemical investigation of new chiral pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides"],"prefix":"10.1038","volume":"15","author":[{"given":"Mateusz","family":"Kciuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Machura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somdutt","family":"Mujwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Marciniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Koszelska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Smarzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Mojzych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Kontek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"2835_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejmech.2017.06.003","volume":"142","author":"S Cascioferro","year":"2017","unstructured":"Cascioferro, S. et al. Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives. Eur. J. Med. Chem. 142, 74\u201386 (2017).","journal-title":"Eur. J. Med. Chem."},{"issue":"Suppl","key":"2835_CR2","first-page":"S94","volume":"12","author":"H Raskov\u00e1","year":"2004","unstructured":"Raskov\u00e1, H. & Z\u00eddek, Z. Surprises and omissions in toxicology. Cent. Eur. J. Public Health 12(Suppl), S94-96 (2004).","journal-title":"Cent. Eur. J. Public Health"},{"key":"2835_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0006-3002(58)90178-1","volume":"29","author":"Y Takagi","year":"1958","unstructured":"Takagi, Y. & Otsuji, N. Studies on the mechanism of action of 6-azauracil. Biochim. Biophys. Acta 29, 227\u2013228 (1958).","journal-title":"Biochim. Biophys. Acta"},{"key":"2835_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1517\/13543780802567250","volume":"18","author":"SB Reddy","year":"2009","unstructured":"Reddy, S. B. & Williamson, S. K. Tirapazamine: a novel agent targeting hypoxic tumor cells. Expert Opin. Investig. Drugs 18, 77\u201387 (2009).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"2835_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/bjc.1993.220","volume":"67","author":"JM Brown","year":"1993","unstructured":"Brown, J. M. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br. J. Cancer 67, 1163\u20131170 (1993).","journal-title":"Br. J. Cancer"},{"key":"2835_CR6","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ejmech.2008.05.026","volume":"44","author":"T Guck\u00fd","year":"2009","unstructured":"Guck\u00fd, T., Frysov\u00e1, I., Slouka, J., Hajd\u00fach, M. & Dzub\u00e1k, P. Cyclocondensation reaction of heterocyclic carbonyl compounds part XIII: synthesis and cytotoxic activity of some 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines. Eur. J. Med. Chem. 44, 891\u2013900 (2009).","journal-title":"Eur. J. Med. Chem."},{"key":"2835_CR7","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.3390\/molecules25173948","volume":"25","author":"Z Bernat","year":"2020","unstructured":"Bernat, Z., Szymanowska, A., Kciuk, M., Kotwica-Mojzych, K. & Mojzych, M. Review of the synthesis and anticancer properties of Pyrazolo[4,3-e][1,2,4]triazine derivatives. Molecules 25, 3948 (2020).","journal-title":"Molecules"},{"key":"2835_CR8","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2174\/0929867033456585","volume":"10","author":"G Bouchain","year":"2003","unstructured":"Bouchain, G. & Delorme, D. Novel Hydroxamate and Anilide derivatives as potent histone deacetylase inhibitors: synthesis and antiproliferative evaluation. Curr. Med. Chem. 10, 2359\u20132372 (2003).","journal-title":"Curr. Med. Chem."},{"key":"2835_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2174\/092986708783497300","volume":"15","author":"X-C Cheng","year":"2008","unstructured":"Cheng, X.-C., Wang, Q., Fang, H. & Xu, W.-F. Role of sulfonamide group in matrix metalloproteinase inhibitors. Curr. Med. Chem. 15, 368\u2013373 (2008).","journal-title":"Curr. Med. Chem."},{"key":"2835_CR10","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","volume":"29","author":"Y Lu","year":"2012","unstructured":"Lu, Y., Chen, J., Xiao, M., Li, W. & Miller, D. D. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm. Res. 29, 2943\u20132971 (2012).","journal-title":"Pharm. Res."},{"key":"2835_CR11","doi-asserted-by":"publisher","first-page":"6616","DOI":"10.1016\/j.bmc.2014.10.009","volume":"22","author":"M Mojzych","year":"2014","unstructured":"Mojzych, M., Dolashki, A. & Voelter, W. Synthesis of pyrazolo[4,3-e][1,2,4]triazine sulfonamides, novel sildenafil analogs with tyrosinase inhibitory activity. Bioorg. Med. Chem. 22, 6616\u20136624 (2014).","journal-title":"Bioorg. Med. Chem."},{"key":"2835_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/14756366.2016.1238362","volume":"32","author":"M Mojzych","year":"2017","unstructured":"Mojzych, M. et al. Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity. J. Enzyme Inhib. Med. Chem. 32, 99\u2013105 (2017).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"2835_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2174\/0929867033457647","volume":"10","author":"A Scozzafava","year":"2003","unstructured":"Scozzafava, A., Owa, T., Mastrolorenzo, A. & Supuran, C. T. Anticancer and antiviral Sulfonamides. Curr. Med. Chem. 10, 925\u2013953 (2003).","journal-title":"Curr. Med. Chem."},{"key":"2835_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejmech.2014.03.054","volume":"78","author":"M Mojzych","year":"2014","unstructured":"Mojzych, M. et al. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines. Eur. J. Med. Chem. 78, 217\u2013224 (2014).","journal-title":"Eur. J. Med. Chem."},{"key":"2835_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1107\/S0907444906047287","volume":"63","author":"SW Cowan-Jacob","year":"2007","unstructured":"Cowan-Jacob, S. W. et al. Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia. Acta Crystallogr. D Biol. Crystallogr. 63, 80\u201393 (2007).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2835_CR16","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1016\/j.bmc.2015.04.011","volume":"23","author":"M Mojzych","year":"2015","unstructured":"Mojzych, M. et al. New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors. Bioorg. Med. Chem. 23, 3674\u20133680 (2015).","journal-title":"Bioorg. Med. Chem."},{"key":"2835_CR17","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.bmcl.2004.02.008","volume":"14","author":"KF Byth","year":"2004","unstructured":"Byth, K. F. et al. Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors. Bioorg. Med. Chem. Lett. 14, 2249\u20132252 (2004).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2835_CR18","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1016\/j.bmcl.2007.05.041","volume":"17","author":"Z Nie","year":"2007","unstructured":"Nie, Z. et al. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2. Bioorg. Med. Chem. Lett. 17, 4191\u20134195 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2835_CR19","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1007\/s00018-009-9151-1","volume":"66","author":"O Filhol","year":"2009","unstructured":"Filhol, O. & Cochet, C. Protein kinase CK2 in health and disease: cellular functions of protein kinase CK2: a dynamic affair. Cell. Mol. Life Sci. CMLS 66, 1830\u20131839 (2009).","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"2835_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/14756366.2018.1530223","volume":"34","author":"ML Sci\u00fa","year":"2019","unstructured":"Sci\u00fa, M. L. et al. Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3. J. Enzyme Inhib. Med. Chem. 34, 87\u201396 (2019).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"2835_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/14756366.2021.1879803","volume":"36","author":"JM Hermanowicz","year":"2021","unstructured":"Hermanowicz, J. M. et al. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer. J. Enzyme Inhib. Med. Chem. 36, 535\u2013548 (2021).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"2835_CR22","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/pharmaceutics13081222","volume":"13","author":"JM Hermanowicz","year":"2021","unstructured":"Hermanowicz, J. M. et al. Preclinical Toxicity and Safety of MM-129-First-in-Class BTK\/PD-L1 Inhibitor as a potential candidate against colon cancer. Pharmaceutics 13, 1222 (2021).","journal-title":"Pharmaceutics"},{"key":"2835_CR23","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.3390\/molecules27123761","volume":"27","author":"K Bukowski","year":"2022","unstructured":"Bukowski, K., Marciniak, B., Kciuk, M., Mojzych, M. & Kontek, R. Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as novel potential anticancer agents: cytotoxic and genotoxic activities in vitro. Molecules 27, 3761 (2022).","journal-title":"Molecules"},{"key":"2835_CR24","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.3390\/ijms23115892","volume":"23","author":"M Kciuk","year":"2022","unstructured":"Kciuk, M. et al. Preparation of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides and Their Experimental and Computational Biological Studies. Int. J. Mol. Sci. 23, 5892 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2835_CR25","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3987\/COM-04-10108","volume":"63","author":"M Mojzych","year":"2004","unstructured":"Mojzych, M. & Rykowski, A. Synthesis of functionalized 1H-Pyrazolo[4,3-e][1,2,4]triazines and their fused derivatives via Ipso-substitution of Methylsulfonyl group with O-, N-. S- and C-Nucleophiles. Heterocycles 63, 1829\u20131838 (2004).","journal-title":"S- and C-Nucleophiles. Heterocycles"},{"key":"2835_CR26","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.3390\/ijms21155221","volume":"21","author":"A Gornowicz","year":"2020","unstructured":"Gornowicz, A., Szymanowska, A., Mojzych, M., Bielawski, K. & Bielawska, A. The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine Sulfonamide derivatives on apoptosis and autophagy in DLD-1 and HT-29 colon cancer cells. Int. J. Mol. Sci. 21, 5221 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2835_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.acthis.2018.02.005","volume":"120","author":"JC Stockert","year":"2018","unstructured":"Stockert, J. C., Horobin, R. W., Colombo, L. L. & Bl\u00e1zquez-Castro, A. Tetrazolium salts and formazan products in cell biology: Viability assessment, fluorescence imaging, and labeling perspectives. Acta Histochem. 120, 159\u2013167 (2018).","journal-title":"Acta Histochem."},{"key":"2835_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.acthis.2018.03.007","volume":"120","author":"E Grela","year":"2018","unstructured":"Grela, E., Koz\u0142owska, J. & Grabowiecka, A. Current methodology of MTT assay in bacteria - A review. Acta Histochem. 120, 303\u2013311 (2018).","journal-title":"Acta Histochem."},{"key":"2835_CR29","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1248\/bpb.25.1600","volume":"25","author":"G Da Violante","year":"2002","unstructured":"Da Violante, G. et al. Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2\/TC7 colon tumor cell cultures. Biol. Pharm. Bull. 25, 1600\u20131603 (2002).","journal-title":"Biol. Pharm. Bull."},{"key":"2835_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-4939-7831-1_24","volume":"1782","author":"S Deshwal","year":"2018","unstructured":"Deshwal, S., Antonucci, S., Kaludercic, N. & Di Lisa, F. Measurement of mitochondrial ROS formation. Methods Mol. Biol. Clifton NJ 1782, 403\u2013418 (2018).","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"2835_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fncel.2016.00076","volume":"10","author":"B Xiao","year":"2016","unstructured":"Xiao, B., Deng, X., Zhou, W. & Tan, E.-K. Flow cytometry-based assessment of Mitophagy using MitoTracker. Front. Cell. Neurosci. 10, 76 (2016).","journal-title":"Front. Cell. Neurosci."},{"key":"2835_CR32","doi-asserted-by":"publisher","first-page":"111512","DOI":"10.1016\/j.biopha.2021.111512","volume":"138","author":"C Hans","year":"2021","unstructured":"Hans, C., Saini, R., Sachdeva, M. U. S. & Sharma, P. 2\u2019,7\u2019-Dichlorofluorescein (DCF) or 2\u2019,7\u2019-dichlorodihydrofluorescein diacetate (DCFH2-DA) to measure reactive oxygen species in erythrocytes. Biomed. Pharmacother. Biomedecine Pharmacother. 138, 111512 (2021).","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"2835_CR33","doi-asserted-by":"publisher","first-page":"e60682","DOI":"10.3791\/60682","volume":"160","author":"H Kim","year":"2020","unstructured":"Kim, H. & Xue, X. Detection of total reactive oxygen species in adherent cells by 2\u2019,7\u2019-Dichlorodihydrofluorescein diacetate staining. J. Vis. Exp. JoVE 160, e60682. https:\/\/doi.org\/10.3791\/60682 (2020).","journal-title":"J. Vis. Exp. JoVE"},{"key":"2835_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/toxres\/tfaa093","volume":"10","author":"E Cordelli","year":"2021","unstructured":"Cordelli, E., Bignami, M. & Pacchierotti, F. Comet assay: a versatile but complex tool in genotoxicity testing. Toxicol. Res. 10, 68\u201378 (2021).","journal-title":"Toxicol. Res."},{"key":"2835_CR35","doi-asserted-by":"publisher","first-page":"111865","DOI":"10.1016\/j.fct.2020.111865","volume":"147","author":"D Muruzabal","year":"2021","unstructured":"Muruzabal, D., Collins, A. & Azqueta, A. The enzyme-modified comet assay Past, present and future. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 147, 111865 (2021).","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"2835_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.trecan.2020.10.006","volume":"7","author":"NA Owiti","year":"2021","unstructured":"Owiti, N. A., Nagel, Z. D. & Engelward, B. P. Fluorescence Sheds Light on DNA Damage, DNA Repair, and Mutations. Trends Cancer 7, 240\u2013248 (2021).","journal-title":"Trends Cancer"},{"key":"2835_CR37","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1038\/s41596-020-0398-1","volume":"15","author":"P M\u00f8ller","year":"2020","unstructured":"M\u00f8ller, P. et al. Minimum information for reporting on the comet assay (MIRCA): recommendations for describing comet assay procedures and results. Nat. Protoc. 15, 3817\u20133826 (2020).","journal-title":"Nat. Protoc."},{"key":"2835_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","volume":"175","author":"NP Singh","year":"1988","unstructured":"Singh, N. P., McCoy, M. T., Tice, R. R. & Schneider, E. L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184\u2013191 (1988).","journal-title":"Exp. Cell Res."},{"key":"2835_CR39","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires, D. E. V., Blundell, T. L. & Ascher, D. B. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"2835_CR40","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"2835_CR41","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1107\/S0907444905015404","volume":"61","author":"A Canals","year":"2005","unstructured":"Canals, A., Purciolas, M., Aymam\u00ed, J. & Coll, M. The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs. Acta Crystallogr. D Biol. Crystallogr. 61, 1009\u20131012 (2005).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2835_CR42","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/cbdd.14038","volume":"99","author":"X Wu","year":"2022","unstructured":"Wu, X., Xu, L.-Y., Li, E.-M. & Dong, G. Application of molecular dynamics simulation in biomedicine. Chem. Biol. Drug Des. 99, 789\u2013800 (2022).","journal-title":"Chem. Biol. Drug Des."},{"key":"2835_CR43","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.3390\/molecules28207005","volume":"28","author":"V Singh","year":"2023","unstructured":"Singh, V., Mujwar, S., Singh, M., Singh, T. & Ahmad, S. F. Computational studies to understand the neuroprotective mechanism of action basil compounds. Molecules 28, 7005 (2023).","journal-title":"Molecules"},{"key":"2835_CR44","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth, S. A. & Dror, R. O. Molecular dynamics simulation for All. Neuron 99, 1129\u20131143 (2018).","journal-title":"Neuron"},{"key":"2835_CR45","first-page":"990","volume":"2011","author":"B Chazotte","year":"2011","unstructured":"Chazotte, B. Labeling mitochondria with MitoTracker dyes. Cold Spring Harb. Protoc. 2011, 990\u2013992 (2011).","journal-title":"Cold Spring Harb. Protoc."},{"key":"2835_CR46","first-page":"prot4493","volume":"2006","author":"S Kasibhatla","year":"2006","unstructured":"Kasibhatla, S. et al. Acridine Orange\/Ethidium Bromide (AO\/EB) Staining to Detect Apoptosis. CSH Protoc. 2006, prot4493 (2006).","journal-title":"CSH Protoc."},{"key":"2835_CR47","first-page":"1","volume":"1","author":"C Lema","year":"2011","unstructured":"Lema, C., Varela-Ramirez, A. & Aguilera, R. J. Differential nuclear staining assay for high-throughput screening to identify cytotoxic compounds. Curr. Cell. Biochem. 1, 1\u201314 (2011).","journal-title":"Curr. Cell. Biochem."},{"key":"2835_CR48","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.redox.2013.12.020","volume":"2","author":"BM Gyori","year":"2014","unstructured":"Gyori, B. M., Venkatachalam, G., Thiagarajan, P. S., Hsu, D. & Clement, M.-V. OpenComet: an automated tool for comet assay image analysis. Redox Biol. 2, 457\u2013465 (2014).","journal-title":"Redox Biol."},{"key":"2835_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/00032719.2014.1003425","volume":"49","author":"J Zavazalova","year":"2016","unstructured":"Zavazalova, J., Prochazkova, K. & Schwarzova-Peckova, K. Boron-doped diamond electrodes for Voltammetric determination of Benzophenone-3. Anal. Lett. 49, 80\u201391 (2016).","journal-title":"Anal. Lett."},{"key":"2835_CR50","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1080\/00945719408001398","volume":"24","author":"DK Gosser","year":"1994","unstructured":"Gosser, D. K. & Jr., VCH, New York, N. Y,. Cyclic voltammetry; simulation and analysis of reaction mechanisms:1993. Synth. React. Inorg. Met. Org. Chem. 24, 1237\u20131238 (1994).","journal-title":"Synth. React. Inorg. Met. Org. Chem."},{"key":"2835_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","volume":"36","author":"Schinkel, null.","year":"1999","unstructured":"Schinkel, null.,. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev. 36, 179\u2013194 (1999).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2835_CR52","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms222312808","volume":"22","author":"M Zhao","year":"2021","unstructured":"Zhao, M. et al. Cytochrome P450 enzymes and drug metabolism in humans. Int. J. Mol. Sci. 22, 12808 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2835_CR53","doi-asserted-by":"publisher","first-page":"D1080","DOI":"10.1093\/nar\/gkv1192","volume":"44","author":"VB Siramshetty","year":"2016","unstructured":"Siramshetty, V. B. et al. WITHDRAWN\u2013a resource for withdrawn and discontinued drugs. Nucleic Acids Res. 44, D1080-1086 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2835_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mrgentox.2019.05.007","volume":"841","author":"E Zeiger","year":"2019","unstructured":"Zeiger, E. The test that changed the world: The Ames test and the regulation of chemicals. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 841, 43\u201348 (2019).","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"2835_CR55","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12859-019-2814-5","volume":"20","author":"H-M Lee","year":"2019","unstructured":"Lee, H.-M. et al. Computational determination of hERG-related cardiotoxicity of drug candidates. BMC Bioinformatics 20, 250 (2019).","journal-title":"BMC Bioinformatics"},{"key":"2835_CR56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2165\/00002018-200528020-00004","volume":"28","author":"J Descotes","year":"2005","unstructured":"Descotes, J. Immunotoxicology: role in the safety assessment of drugs. Drug Saf. 28, 127\u2013136 (2005).","journal-title":"Drug Saf."},{"key":"2835_CR57","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.talanta.2011.08.034","volume":"85","author":"S Nussbaumer","year":"2011","unstructured":"Nussbaumer, S., Bonnabry, P., Veuthey, J.-L. & Fleury-Souverain, S. Analysis of anticancer drugs: a review. Talanta 85, 2265\u20132289 (2011).","journal-title":"Talanta"},{"key":"2835_CR58","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","volume":"21","author":"K Bukowski","year":"2020","unstructured":"Bukowski, K., Kciuk, M. & Kontek, R. Mechanisms of multidrug resistance in cancer chemotherapy. Int. J. Mol. Sci. 21, 3233 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2835_CR59","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"RB Mokhtari","year":"2017","unstructured":"Mokhtari, R. B. et al. Combination therapy in combating cancer. Oncotarget 8, 38022\u201338043 (2017).","journal-title":"Oncotarget"},{"key":"2835_CR60","first-page":"35","volume":"14","author":"YA Luqmani","year":"2005","unstructured":"Luqmani, Y. A. Mechanisms of drug resistance in cancer chemotherapy. Med. Princ. Pract Int. J. Kuwait Univ. Health Sci. Cent. 14, 35\u201348 (2005).","journal-title":"Med. Princ. Pract Int. J. Kuwait Univ. Health Sci. Cent."},{"key":"2835_CR61","doi-asserted-by":"publisher","first-page":"2343352","DOI":"10.1080\/14756366.2024.2343352","volume":"39","author":"A Szymanowska","year":"2024","unstructured":"Szymanowska, A. et al. The activity of pyrazolo[4,3-e][1,2,4]triazine and pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures. J. Enzyme Inhib. Med. Chem. 39, 2343352 (2024).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"2835_CR62","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/ph15091071","volume":"15","author":"AK Singh","year":"2022","unstructured":"Singh, A. K. et al. Concept of hybrid drugs and recent advancements in anticancer hybrids. Pharmaceuticals 15, 1071 (2022).","journal-title":"Pharmaceuticals"},{"key":"2835_CR63","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1039\/D4RA03200D","volume":"15","author":"F Shi","year":"2025","unstructured":"Shi, F. et al. Synthesis, biological and pharmacokinetic characterization of a novel leucine Ureido derivative as a multi-target anticancer agent. RSC Adv. 15, 4348\u20134355 (2025).","journal-title":"RSC Adv."},{"key":"2835_CR64","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/CAD.0000000000000842","volume":"31","author":"H Yang","year":"2020","unstructured":"Yang, H. et al. Inhibition of the proliferation, migration, and invasion of human breast cancer cells by leucine aminopeptidase 3 inhibitors derived from natural marine products. Anticancer. Drugs 31, 60\u201366 (2020).","journal-title":"Anticancer. Drugs"},{"key":"2835_CR65","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.bmc.2019.01.041","volume":"27","author":"J Cao","year":"2019","unstructured":"Cao, J. et al. Leucine Ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II. Bioorg. Med. Chem. 27, 978\u2013990 (2019).","journal-title":"Part II. Bioorg. Med. Chem."},{"key":"2835_CR66","first-page":"193","volume":"31","author":"PP de Castro","year":"2020","unstructured":"de Castro, P. P. et al. Cytotoxic activity of synthetic chiral amino acid derivatives. J. Braz. Chem. Soc. 31, 193\u2013200 (2020).","journal-title":"J. Braz. Chem. Soc."},{"key":"2835_CR67","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41467-025-56903-w","volume":"16","author":"Y Lee","year":"2025","unstructured":"Lee, Y. et al. Structural basis of anticancer drug recognition and amino acid transport by LAT1. Nat. Commun. 16, 1635 (2025).","journal-title":"Nat. Commun."},{"key":"2835_CR68","first-page":"7230","volume":"28","author":"M Kciuk","year":"2023","unstructured":"Kciuk, M. et al. Synthesis, computational, and anticancer in vitro investigations of Aminobenzylnaphthols derived from 2-Naphtol, Benzaldehydes, and \u03b1-Aminoacids via the Betti reaction. Mol. Basel Switz. 28, 7230 (2023).","journal-title":"Mol. Basel Switz."},{"key":"2835_CR69","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3390\/ijms24044053","volume":"24","author":"M Kciuk","year":"2023","unstructured":"Kciuk, M. et al. Genotoxicity of novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides in normal and cancer cells in vitro. Int. J. Mol. Sci. 24, 4053 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2835_CR70","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.3390\/ijms23073524","volume":"23","author":"M Czaja","year":"2022","unstructured":"Czaja, M. et al. Raman research on bleomycin-Induced DNA strand breaks and repair processes in living cells. Int. J. Mol. Sci. 23, 3524 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2835_CR71","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1093\/nar\/gkn302","volume":"36","author":"J Chen","year":"2008","unstructured":"Chen, J., Ghorai, M. K., Kenney, G. & Stubbe, J. Mechanistic studies on bleomycin-mediated DNA damage: multiple binding modes can result in double-stranded DNA cleavage. Nucleic Acids Res. 36, 3781\u20133790 (2008).","journal-title":"Nucleic Acids Res."},{"key":"2835_CR72","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s12013-024-01384-9","volume":"82","author":"SM Mohammed","year":"2024","unstructured":"Mohammed, S. M. et al. Mechanisms of bleomycin-induced lung fibrosis: a review of therapeutic targets and approaches. Cell Biochem. Biophys. 82, 1845\u20131870. https:\/\/doi.org\/10.1007\/s12013-024-01384-9 (2024).","journal-title":"Cell Biochem. Biophys."},{"key":"2835_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-411636-8.00001-8","volume":"92","author":"A Mukherjee","year":"2013","unstructured":"Mukherjee, A. & Sasikala, W. D. Drug-DNA intercalation: from discovery to the molecular mechanism. Adv. Protein Chem. Struct. Biol. 92, 1\u201362 (2013).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"2835_CR74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.copbio.2007.09.006","volume":"18","author":"R Palchaudhuri","year":"2007","unstructured":"Palchaudhuri, R. & Hergenrother, P. J. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr. Opin. Biotechnol. 18, 497\u2013503 (2007).","journal-title":"Curr. Opin. Biotechnol."},{"key":"2835_CR75","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/cbdd.14116","volume":"100","author":"S Venugopal","year":"2022","unstructured":"Venugopal, S., Sharma, V., Mehra, A., Singh, I. & Singh, G. DNA intercalators as anticancer agents. Chem. Biol. Drug Des. 100, 580\u2013598 (2022).","journal-title":"Chem. Biol. Drug Des."},{"key":"2835_CR76","doi-asserted-by":"publisher","first-page":"10959","DOI":"10.3390\/ijms241310959","volume":"24","author":"M Kciuk","year":"2023","unstructured":"Kciuk, M. et al. Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as an important scaffold for anticancer drug discovery-in vitro and in silico evaluation. Int. J. Mol. Sci. 24, 10959 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2835_CR77","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.3390\/cancers13133203","volume":"13","author":"JM Hermanowicz","year":"2021","unstructured":"Hermanowicz, J. M. et al. MM-129 as a novel inhibitor targeting PI3K\/AKT\/mTOR and PD-L1 in colorectal cancer. Cancers 13, 3203 (2021).","journal-title":"Cancers"},{"key":"2835_CR78","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/cancers16010122","volume":"16","author":"I Kwiatkowska","year":"2023","unstructured":"Kwiatkowska, I. et al. Assessment of an anticancer effect of the simultaneous administration of MM-129 and indoximod in the colorectal cancer model. Cancers 16, 122 (2023).","journal-title":"Cancers"},{"key":"2835_CR79","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.2174\/0929867323666160809093930","volume":"23","author":"D Kumar","year":"2016","unstructured":"Kumar, D. & Jain, S. K. A comprehensive review of N-Heterocycles as cytotoxic agents. Curr. Med. Chem. 23, 4338\u20134394 (2016).","journal-title":"Curr. Med. Chem."},{"key":"2835_CR80","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.2174\/1871520622666220404082648","volume":"22","author":"N Kumar","year":"2022","unstructured":"Kumar, N. & Goel, N. Heterocyclic compounds: importance in anticancer drug discovery. Anticancer Agents Med. Chem. 22, 3196\u20133207 (2022).","journal-title":"Anticancer Agents Med. Chem."},{"key":"2835_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jmgm.2004.03.016","volume":"23","author":"HB Broughton","year":"2004","unstructured":"Broughton, H. B. & Watson, I. A. Selection of heterocycles for drug design. J. Mol. Graph. Model. 23, 51\u201358 (2004).","journal-title":"J. Mol. Graph. Model."},{"key":"2835_CR82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2174\/0115734064278334231211054053","volume":"20","author":"T Biswas","year":"2024","unstructured":"Biswas, T., Mittal, R. K., Sharma, V. & Kanupriya, null & Mishra, I.,. Nitrogen-fused heterocycles: empowering anticancer drug discovery. Med. Chem. Shariqah U. A. E. 20, 369\u2013384. https:\/\/doi.org\/10.2174\/0115734064278334231211054053 (2024).","journal-title":"Med. Chem. Shariqah U. A. E."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02835-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02835-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02835-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:02:26Z","timestamp":1748430146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02835-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2835"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02835-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The use of a human leucocyte buffy-coat was approved by the Bioethics Committee for Scientific Investigation, University of Lodz (agreement no. KBBN-U\u0141\/I\/8\/2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}}],"article-number":"18640"}}